Related Experiment Video
Updated: Dec 24, 2025

CAM-Delam Assay to Score Metastatic Properties by Quantifying Delamination and Invasion Capacity of Cancer Cells
Published on: June 2, 2022
Integrin and Heparan Sulfate Dual-Targeting Peptide Assembly Suppresses Cancer Metastasis
Sona Rani Roy1, Guanying Li1, Xunwu Hu1
1Bioinspired Soft Matter Unit, Okinawa Institute of Science and Technology Graduate University, 1919-1 Tancha, Onna-son, Okinawa 904-0495, Japan.
Abstract:
Metastasis is one of the ongoing challenges in cancer therapy which most treatments failed to address. Inspired by the upregulated expression of both integrin β1 and heparan sulfate in metastatic tumors, we developed an integrin/HS dual-targeting peptide assembly that selectively inhibits cancer cell migration and invasion. Particularly, the dual-targeting peptide self-assembles into nanofibrous microdomains specifically on the cancer cell membrane, triggering spatial organization of integrins, which form clusters on the apical membrane. Via the actin cytoskeleton that physically connects to integrin clusters, the oncogene yes-associated protein, which regulates cancer metastasis, is deactivated. We showed that in multiple cancer cell lines, including the highly metastatic pancreatic cancer cells, the dual-targeting peptide exerts potent and dose-dependent antimetastatic effects. Our work illustrates how basic biochemical insights can be exploited as the basis for nano-biointerface fabrication, which is potentially a general design strategy for nanomedicine development.
Insights
Researchers developed a dual-targeting peptide assembly to inhibit cancer metastasis by targeting integrin β1 and heparan sulfate. This peptide assembly effectively reduces cancer cell migration and invasion, offering a promising nanomedicine strategy.
Area of Science:
- Biochemistry
- Nanomedicine
- Cancer Biology
Background:
- Metastasis remains a significant challenge in cancer therapy, with many treatments proving ineffective.
- Upregulated expression of integrin β1 and heparan sulfate is observed in metastatic tumors.
Purpose of the Study:
- To develop a novel peptide assembly targeting both integrin β1 and heparan sulfate (HS) to inhibit cancer metastasis.
- To investigate the mechanism of action of the dual-targeting peptide on cancer cell migration and invasion.
Main Methods:
- Development of a self-assembling peptide targeting integrin β1 and HS.
- Investigation of peptide self-assembly into nanofibrous microdomains on cancer cell membranes.
- Analysis of integrin clustering, actin cytoskeleton involvement, and yes-associated protein deactivation.
Main Results:
- The dual-targeting peptide self-assembles into nanofibrous microdomains on cancer cell membranes.
- This assembly triggers integrin clustering, leading to the deactivation of the oncogene yes-associated protein via the actin cytoskeleton.
- Potent and dose-dependent inhibition of cancer cell migration and invasion was observed in multiple cancer cell lines, including pancreatic cancer.
Conclusions:
- The developed integrin/HS dual-targeting peptide assembly effectively inhibits cancer metastasis.
- This approach demonstrates a potential general design strategy for nanomedicine development based on nano-biointerface fabrication.
More Related Videos
06:27A 3D Spheroid Model as a More Physiological System for Cancer-Associated Fibroblasts Differentiation and Invasion In Vitro Studies
Published on: August 8, 2019
07:39The Establishment of a Lung Colonization Assay for Circulating Tumor Cell Visualization in Lung Tissues
Published on: June 16, 2018
Related Concept Videos
Cancer Cell Migration through Invadopodia
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Selectins
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
Intracellular Signaling Affects Focal Adhesions
Some...